{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:40:56Z","timestamp":1788932456055,"version":"build-2803163510"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T00:00:00Z","timestamp":1542844800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"DOI":"10.3389\/fcvm.2018.00170","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T08:53:44Z","timestamp":1545123224000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Beta-1-Adrenergic Receptor Antibodies in Acute Coronary Syndrome: Is Less Sometimes More?"],"prefix":"10.3389","volume":"5","author":[{"given":"Diana","family":"Ernst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Widera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Weiberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Derlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerrit","family":"Ahrenstorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Sogkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Jablonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Heidecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Riemekasten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jacc.2012.11.002","article-title":"The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology","volume":"60","author":"Laslett","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2017.02.010","article-title":"Anti-MYC-associated zinc finger protein antibodies are associated with inflammatory atherosclerotic lesions on 18F-fluorodeoxyglucose positron emission tomography","volume":"259","author":"Ernst","year":"2017","journal-title":"Atherosclerosis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3389\/fimmu.2017.01595","article-title":"Antibodies against MYC-associated zinc finger protein: an independent marker in acute coronary syndrome?","volume":"8","author":"Ernst","year":"2017","journal-title":"Front Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.autrev.2016.03.014","article-title":"Autoimmune atherosclerosis in 3D: how it develops, how to diagnose and what to do","volume":"15","author":"Szekanecz","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1160\/TH12-10-0768","article-title":"Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases","volume":"109","author":"Carbone","year":"2013","journal-title":"Thromb Haemost."},{"key":"B7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/VHRM.S45704","article-title":"Emerging families of biomarkers for coronary artery disease: inflammatory mediators","volume":"9","author":"Yayan","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"B8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1161\/CIRCULATIONAHA.106.650846","article-title":"Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome","volume":"115","author":"Wollert","year":"2007","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/S0002-8703(05)80182-6","article-title":"Influence of anti-beta-receptor antibodies on cardiac adenylate cyclase in patients with idiopathic dilated cardiomyopathy","volume":"119","author":"Limas","year":"1990","journal-title":"Am Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1161\/01.CIR.99.5.649","article-title":"Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure","volume":"99","author":"Jahns","year":"1999","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/08916930701619235","article-title":"Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy","volume":"41","author":"Caforio","year":"2008","journal-title":"Autoimmunity"},{"key":"B12","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jacc.2016.11.067","article-title":"Myocardial recovery in patients with systolic heart failure and autoantibodies against beta1-adrenergic receptors","volume":"69","author":"Nagatomo","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cardfail.2016.03.005","article-title":"Autoantibodies specifically against beta1 adrenergic receptors and adverse clinical outcome in patients with chronic systolic heart failure in the beta-blocker era: the importance of immunoglobulin G3 subclass","volume":"22","author":"Nagatomo","year":"2016","journal-title":"J Card Fail."},{"key":"B14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12016-010-8228-9","article-title":"The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease","volume":"44","author":"Nussinovitch","year":"2013","journal-title":"Clin Rev Allergy Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejphar.2015.05.019","article-title":"GPCR signaling and cardiac function","volume":"763","author":"Capote","year":"2015","journal-title":"Eur J Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.cjca.2013.09.017","article-title":"beta1-selective adrenoceptor antagonists increase plasma levels of anti-p2beta antibodies and decrease cardiac involvement in chronic progressive Chagas heart disease","volume":"30","author":"Vicco","year":"2014","journal-title":"Can J Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1476-5381.2012.01828.x","article-title":"Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart function","volume":"166","author":"Herda","year":"2012","journal-title":"Br J Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.autrev.2007.06.001","article-title":"Functional autoantibodies, a new paradigm in autoimmunity?","volume":"7","author":"Gleicher","year":"2007","journal-title":"Autoimmun Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.2967\/jnumed.110.076471","article-title":"Feasibility of 18F-sodium fluoride PET\/CT for imaging of atherosclerotic plaque","volume":"51","author":"Derlin","year":"2010","journal-title":"J Nucl Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1373\/clinchem.2009.129411","article-title":"Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay","volume":"55","author":"Widera","year":"2009","journal-title":"Clin Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ijcard.2015.10.068","article-title":"Detection of DCM-associated beta1-adrenergic receptor autoantibodies requires functional readouts or native human beta1-receptors as targets","volume":"202","author":"Bornholz","year":"2016","journal-title":"Int J Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1515\/cclm-2015-0603","article-title":"A standardised FACS assay based on native, receptor transfected cells for the clinical diagnosis and monitoring of beta1-adrenergic receptor autoantibodies in human heart disease","volume":"54","author":"Bornholz","year":"2016","journal-title":"Clin Chem Lab Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1208\/s12248-014-9696-2","article-title":"Workshop report: crystal city V\u2013quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidance","volume":"17","author":"Booth","year":"2015","journal-title":"AAPS J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nrrheum.2017.134","article-title":"Functional autoantibodies targeting G protein-coupled receptors in rheumatic diseases","volume":"13","author":"Cabral-Marques","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00281-014-0425-9","article-title":"Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases","volume":"36","author":"Wallukat","year":"2014","journal-title":"Semin Immunopathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13075-018-1545-8","article-title":"Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis","volume":"20","author":"Weigold","year":"2018","journal-title":"Arthritis Res Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/cvr\/cvs350","article-title":"Impact of human autoantibodies on beta1-adrenergic receptor conformation, activity, and internalization","volume":"97","author":"Bornholz","year":"2013","journal-title":"Cardiovasc Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0167-5273(96)02590-9","article-title":"Beta 1-adrenoceptor autoimmunity in cardiomyopathy","volume":"54","author":"Magnusson","year":"1996","journal-title":"Int J Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0022-2828(08)80040-5","article-title":"Regulation of beta-adrenergic receptors in acute myocardial ischemia: subtype-selective increase of mRNA specific for beta 1-adrenergic receptors","volume":"27","author":"Ihl-Vahl","year":"1995","journal-title":"J Mol Cell Cardiol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/eurheartj\/12.suppl_F.54","article-title":"Pathophysiology of the beta-adrenoceptor system in chronic heart failure: consequences for treatment with agonists, partial agonists or antagonists?","volume":"12","author":"Brodde","year":"1991","journal-title":"Eur Heart J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2967\/jnumed.110.081208","article-title":"In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET\/CT: correlation with atherogenic risk factors","volume":"52","author":"Derlin","year":"2011","journal-title":"J Nucl Med."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2018.00170\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T08:53:46Z","timestamp":1545123226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcvm.2018.00170\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,22]]},"references-count":32,"alternative-id":["10.3389\/fcvm.2018.00170"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2018.00170","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,22]]},"article-number":"170"}}